Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$654M |
| 2 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$241M |
| 3 |
iShares Gold Trust
IAU
|
+$232M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$200M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Carvana
CVNA
|
+$540M |
| 4 |
Target
TGT
|
+$430M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 5.96% |
| 3 | Consumer Discretionary | 5.3% |
| 4 | Healthcare | 4.99% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGTI
2826
DELISTED
PGT, Inc.
PGTI
| $1.11M | ﹤0.01% |
61,937
+3,964
| +7% | +$80.2K |
|
|
SWAV
2827
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.11M | ﹤0.01% |
5,365
-9,518
| -64% | -$1.57M |
|
2828
Terex
TEX
$7.18B
| $1.11M | ﹤0.01% |
31,098
-20,060
| -39% | -$830K |
|
|
SLN
2829
Silence Therapeutics
SLN
$495M
| $1.11M | ﹤0.01% |
58,333
| – | – |
|
|
CNR
2830
Core Natural Resources Inc
CNR
$4.02B
| $1.11M | ﹤0.01% |
29,430
+1,739
| +6% | +$50.4K |
|
|
FNTC
2831
DELISTED
Direxion Daily FinTech Bull 2X Shares
FNTC
| $1.11M | ﹤0.01% |
+50,000
| New | +$1.12M |
|
2832
Penumbra
PEN
$12.7B
| $1.11M | ﹤0.01% |
4,979
+1,534
| +45% | +$341K |
|
2833
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.5B
| $1.1M | ﹤0.01% |
32,564
-3,126
| -9% | -$106K |
|
2834
Progyny
PGNY
$2.44B
| $1.1M | ﹤0.01% |
21,484
-6,259
| -23% | -$268K |
|
2835
BRC Group Holdings
RILY
$288M
| $1.1M | ﹤0.01% |
15,782
-5
| -0% | -$339 |
|
2836
Yelp
YELP
$1.45B
| $1.1M | ﹤0.01% |
32,349
-14,206
| -31% | -$488K |
|
2837
StoneX
SNEX
$9.26B
| $1.1M | ﹤0.01% |
75,107
+9,765
| +15% | +$136K |
|
2838
National Presto Industries
NPK
$870M
| $1.1M | ﹤0.01% |
14,303
+1,730
| +14% | +$140K |
|
|
SWTX
2839
DELISTED
SpringWorks Therapeutics
SWTX
| $1.1M | ﹤0.01% |
19,504
-48,214
| -71% | -$2.76M |
|
|
ACRE
2840
Ares Commercial Real Estate
ACRE
$236M
| $1.1M | ﹤0.01% |
70,737
-71,903
| -50% | -$1.06M |
|
2841
iShare MSCI Eurozone ETF
EZU
$9.64B
| $1.1M | ﹤0.01% |
25,345
+15,318
| +153% | +$697K |
|
|
AZEK
2842
DELISTED
The AZEK Co
AZEK
| $1.09M | ﹤0.01% |
44,081
-2,162
| -5% | -$68K |
|
2843
PUT
Global Payments
GPN
$23B
| $1.09M | ﹤0.01% |
8,000
-2,000
| -20% | -$279K |
|
2844
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.09M | ﹤0.01% |
67,064
-321,814
| -83% | -$5.16M |
|
2845
Allogene Therapeutics
ALLO
$649M
| $1.09M | ﹤0.01% |
119,165
-146,219
| -55% | -$1.52M |
|
|
BRKL
2846
DELISTED
Brookline Bancorp
BRKL
| $1.08M | ﹤0.01% |
68,504
+3,284
| +5% | +$55.4K |
|
2847
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$258M
| $1.08M | ﹤0.01% |
9,476
+1,754
| +23% | +$201K |
|
|
EVBG
2848
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.08M | ﹤0.01% |
24,750
+4,861
| +24% | +$230K |
|
|
NBP
2849
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $1.08M | ﹤0.01% |
66,441
+44,264
| +200% | +$1.13M |
|
2850
e.l.f. Beauty
ELF
$4.89B
| $1.08M | ﹤0.01% |
41,711
+4,617
| +12% | +$126K |
|
Similar funds
Citigroup's Q1 2022 Portfolio in Review
As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.
- Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
- Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
- Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
- Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
- Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.